This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bailey, J. R.
Right arrow Articles by Siliciano, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bailey, J. R.
Right arrow Articles by Siliciano, R. F.

 Previous Article  |  Next Article 

Journal of Virology, July 2006, p. 6441-6457, Vol. 80, No. 13
0022-538X/06/$08.00+0     doi:10.1128/JVI.00591-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells{dagger}

Justin R. Bailey,1,{ddagger} Ahmad R. Sedaghat,1,{ddagger} Tara Kieffer,1,{ddagger} Timothy Brennan,1 Patricia K. Lee,1 Megan Wind-Rotolo,1 Christine M. Haggerty,1 Ashrit R. Kamireddi,1 Yi Liu,1 Jessica Lee,1 Deborah Persaud,2 Joel E. Gallant,1 Joseph Cofrancesco Jr.,1 Thomas C. Quinn,1,3 Claus O. Wilke,4 Stuart C. Ray,1 Janet D. Siliciano,1 Richard E. Nettles,1 and Robert F. Siliciano1,5*

Departments of Medicine,1 Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205,2 National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892,3 Section of Integrative Biology, University of Texas at Austin, Austin, Texas 78713,4 Howard Hughes Medical Institute, Baltimore, Maryland 212055

Received 23 March 2006/ Accepted 19 April 2006

Antiretroviral therapy can reduce human immunodeficiency virus type 1 (HIV-1) viremia to below the detection limit of ultrasensitive clinical assays (50 copies of HIV-1 RNA/ml). However, latent HIV-1 persists in resting CD4+ T cells, and low residual levels of free virus are found in the plasma. Limited characterization of this residual viremia has been done because of the low number of virions per sample. Using intensive sampling, we analyzed residual viremia and compared these viruses to latent proviruses in resting CD4+ T cells in peripheral blood. For each patient, we found some viruses in the plasma that were identical to viruses in resting CD4+ T cells by pol gene sequencing. However, in a majority of patients, the most common viruses in the plasma were rarely found in resting CD4+ T cells even when the resting cell compartment was analyzed with assays that detect replication-competent viruses. Despite the large diversity of pol sequences in resting CD4+ T cells, the residual viremia was dominated by a homogeneous population of viruses with identical pol sequences. In the most extensively studied case, a predominant plasma sequence was also found in analysis of the env gene, and linkage by long-distance reverse transcriptase PCR established that these predominant plasma sequences represented a single predominant plasma virus clone. The predominant plasma clones were released for months to years without evident sequence change. Thus, in some patients on antiretroviral therapy, the major mechanism for residual viremia involves prolonged production of a small number of viral clones without evident evolution, possibly by cells other than circulating CD4+ T cells.

* Corresponding author. Mailing address: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205. Phone: (410) 955-2958. Fax: (443) 287-6218. E-mail: rsiliciano{at}jhmi.edu.

{dagger} Supplemental material for this article may be found at http://jvi.asm.org/.

{ddagger} These authors contributed equally to this work.

Journal of Virology, July 2006, p. 6441-6457, Vol. 80, No. 13
0022-538X/06/$08.00+0     doi:10.1128/JVI.00591-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Shiu, C., Cunningham, C. K., Greenough, T., Muresan, P., Sanchez-Merino, V., Carey, V., Jackson, J. B., Ziemniak, C., Fox, L., Belzer, M., Ray, S. C., Luzuriaga, K., Persaud, D., and the Pediatric AIDS Clinical Trials Group P1059, (2009). Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral Therapy. J. Virol. 83: 9731-9742 [Abstract] [Full Text]  
  • Buendia, P., Cadwallader, B., DeGruttola, V. (2009). A phylogenetic and Markov model approach for the reconstruction of mutational pathways of drug resistance. Bioinformatics 25: 2522-2529 [Abstract] [Full Text]  
  • Dinoso, J. B., Rabi, S. A., Blankson, J. N., Gama, L., Mankowski, J. L., Siliciano, R. F., Zink, M. C., Clements, J. E. (2009). A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy. J. Virol. 83: 9247-9257 [Abstract] [Full Text]  
  • Onafuwa-Nuga, A., Telesnitsky, A. (2009). The Remarkable Frequency of Human Immunodeficiency Virus Type 1 Genetic Recombination. Microbiol. Mol. Biol. Rev. 73: 451-480 [Abstract] [Full Text]  
  • Brennan, T. P., Woods, J. O., Sedaghat, A. R., Siliciano, J. D., Siliciano, R. F., Wilke, C. O. (2009). Analysis of Human Immunodeficiency Virus Type 1 Viremia and Provirus in Resting CD4+ T Cells Reveals a Novel Source of Residual Viremia in Patients on Antiretroviral Therapy. J. Virol. 83: 8470-8481 [Abstract] [Full Text]  
  • Beloukas, A., Paraskevis, D., Haida, C., Sypsa, V., Hatzakis, A. (2009). Development and Assessment of a Multiplex Real-Time PCR Assay for Quantification of Human Immunodeficiency Virus Type 1 DNA. J. Clin. Microbiol. 47: 2194-2199 [Abstract] [Full Text]  
  • Bull, M. E., Learn, G. H., McElhone, S., Hitti, J., Lockhart, D., Holte, S., Dragavon, J., Coombs, R. W., Mullins, J. I., Frenkel, L. M. (2009). Monotypic Human Immunodeficiency Virus Type 1 Genotypes across the Uterine Cervix and in Blood Suggest Proliferation of Cells with Provirus. J. Virol. 83: 6020-6028 [Abstract] [Full Text]  
  • Dinoso, J. B., Kim, S. Y., Wiegand, A. M., Palmer, S. E., Gange, S. J., Cranmer, L., O'Shea, A., Callender, M., Spivak, A., Brennan, T., Kearney, M. F., Proschan, M. A., Mican, J. M., Rehm, C. A., Coffin, J. M., Mellors, J. W., Siliciano, R. F., Maldarelli, F. (2009). Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 106: 9403-9408 [Abstract] [Full Text]  
  • Sundstrom, J. B., Hair, G. A., Ansari, A. A., Secor, W. E., Gilfillan, A. M., Metcalfe, D. D., Kirshenbaum, A. S. (2009). IgE-Fc{epsilon}RI Interactions Determine HIV Coreceptor Usage and Susceptibility to Infection during Ontogeny of Mast Cells. J. Immunol. 182: 6401-6409 [Abstract] [Full Text]  
  • Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., Pomerantz, R. J. (2009). The Challenge of Finding a Cure for HIV Infection. Science 323: 1304-1307 [Abstract] [Full Text]  
  • Marsden, M. D., Zack, J. A. (2009). Eradication of HIV: current challenges and new directions. J Antimicrob Chemother 63: 7-10 [Abstract] [Full Text]  
  • McMahon, M. A., Siliciano, J. D., Lai, J., Liu, J. O., Stivers, J. T., Siliciano, R. F., Kohli, R. M. (2008). The Antiherpetic Drug Acyclovir Inhibits HIV Replication and Selects the V75I Reverse Transcriptase Multidrug Resistance Mutation. J. Biol. Chem. 283: 31289-31293 [Abstract] [Full Text]  
  • Joos, B., Fischer, M., Kuster, H., Pillai, S. K., Wong, J. K., Boni, J., Hirschel, B., Weber, R., Trkola, A., Gunthard, H. F., The Swiss HIV Cohort Study, (2008). HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc. Natl. Acad. Sci. USA 105: 16725-16730 [Abstract] [Full Text]  
  • (2008). Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle. Proc. Natl. Acad. Sci. USA 105: 4832-4837  
  • Palmer, S., Maldarelli, F., Wiegand, A., Bernstein, B., Hanna, G. J., Brun, S. C., Kempf, D. J., Mellors, J. W., Coffin, J. M., King, M. S. (2008). Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc. Natl. Acad. Sci. USA 105: 3879-3884 [Abstract] [Full Text]  
  • DeGottardi, M. Q., Lew, S. K., Piatak, M. Jr., Jia, B., Feng, Y., Lee, S. J., Brenchley, J. M., Douek, D. C., Kodama, T., Lifson, J. D., Evans, D. T. (2008). Comparison of Plasma Viremia and Antibody Responses in Macaques Inoculated with Envelope Variants of Single-Cycle Simian Immunodeficiency Virus Differing in Infectivity and Cellular Tropism. J. Virol. 82: 321-334 [Abstract] [Full Text]  
  • Ambrose, Z., Palmer, S., Boltz, V. F., Kearney, M., Larsen, K., Polacino, P., Flanary, L., Oswald, K., Piatak, M. Jr., Smedley, J., Shao, W., Bischofberger, N., Maldarelli, F., Kimata, J. T., Mellors, J. W., Hu, S.-L., Coffin, J. M., Lifson, J. D., KewalRamani, V. N. (2007). Suppression of Viremia and Evolution of Human Immunodeficiency Virus Type 1 Drug Resistance in a Macaque Model for Antiretroviral Therapy. J. Virol. 81: 12145-12155 [Abstract] [Full Text]  
  • Kaiser, P., Joos, B., Niederost, B., Weber, R., Gunthard, H. F., Fischer, M., the Swiss HIV Cohort Study, (2007). Productive Human Immunodeficiency Virus Type 1 Infection in Peripheral Blood Predominantly Takes Place in CD4/CD8 Double-Negative T Lymphocytes. J. Virol. 81: 9693-9706 [Abstract] [Full Text]  
  • McMahon, M. A., Jilek, B. L., Brennan, T. P., Shen, L., Zhou, Y., Wind-Rotolo, M., Xing, S., Bhat, S., Hale, B., Hegarty, R., Chong, C. R., Liu, J. O., Siliciano, R. F., Thio, C. L. (2007). The HBV Drug Entecavir -- Effects on HIV-1 Replication and Resistance. NEJM 356: 2614-2621 [Abstract] [Full Text]  
  • Sundstrom, J. B., Ellis, J. E., Hair, G. A., Kirshenbaum, A. S., Metcalfe, D. D., Yi, H., Cardona, A. C., Lindsay, M. K., Ansari, A. A. (2007). Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood 109: 5293-5300 [Abstract] [Full Text]  
  • Wojcechowskyj, J. A., Yant, L. J., Wiseman, R. W., O'Connor, S. L., O'Connor, D. H. (2007). Control of Simian Immunodeficiency Virus SIVmac239 Is Not Predicted by Inheritance of Mamu-B*17-Containing Haplotypes. J. Virol. 81: 406-410 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»